Updated Jul 16, 2026
Aryeh Jason has filed 5 SEC Form 4 filings across 3 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $40K. Lifetime open-market sales: $2.96M.
Aryeh Jason is a corporate director with experience in the biotechnology and pharmaceutical industries. He has served on the boards of multiple companies, including LifeCore Biomedical, Inc., Ligand Pharmaceuticals Inc., and Orchestra BioMed Holdings, Inc.
| Role | Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | LGND | LIGAND PHARMACEUTICALS INC | S — Open-market sale | 4.5K | $250.00 | $1.12M |
| 2026-06-12 | LGND | LIGAND PHARMACEUTICALS INC | S — Open-market sale | 500 | $250.00 | $125K |
| 2026-06-12 | LGND | LIGAND PHARMACEUTICALS INC | A — Grant or award | 836 | $0.00 | |
| 2026-06-05 | LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | A — Grant or award | 25.9K | — | |
| 2026-05-20 | OBIO | Orchestra BioMed Holdings, Inc. | P — Open-market purchase | 665 | $3.75 | $2K |
| 2026-05-19 | OBIO | Orchestra BioMed Holdings, Inc. | P — Open-market purchase | 9.0K | $3.90 | $35K |
| 2025-09-23 | LGND | LIGAND PHARMACEUTICALS INC | S — Open-market sale | 954 | $171.92 | $164K |
| 2025-09-23 | LGND | LIGAND PHARMACEUTICALS INC | S — Open-market sale | 4.6K | $170.96 | $791K |
| 2025-09-23 | LGND | LIGAND PHARMACEUTICALS INC | S — Open-market sale | 4.4K | $170.41 | $753K |
| 2025-09-19 | OBIO | Orchestra BioMed Holdings, Inc. | P — Open-market purchase | 1.0K | $2.45 | $2K |
| 2025-08-07 | OBIO | Orchestra BioMed Holdings, Inc. | A — Grant or award | 15.0K | $0.00 | |
| 2025-07-15 | LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | A — Grant or award | 19.5K | — | |
| 2024-12-30 | OBIO | Orchestra BioMed Holdings, Inc. | M — Option exercise | 11.7K | $4.30 | $50K |
Aryeh Jason is a corporate director with experience in the biotechnology and pharmaceutical industries. He has served on the boards of multiple companies, including LifeCore Biomedical, Inc., Ligand Pharmaceuticals Inc., and Orchestra BioMed Holdings, Inc.…
5 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 3 open-market purchases ($40K) and 5 open-market sales ($2.96M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Aryeh Jason profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.